Brief: China Regenerative Medicine International Proposes To Implement Share Consolidation
14/07/2023 16:47
July 14 (Reuters) - China Regenerative Medicine
International Ltd 8158.HK :
* PROPOSES TO IMPLEMENT SHARE CONSOLIDATION
* CONSOLIDATION ON BASIS THAT EVERY 10 SHARES WILL BE
CONSOLIDATED
INTO 1 CONSOLIDATED SHARE
* CONDITIONALLY AGREED TO ISSUE 18.8 MILLION SUBSCRIPTION
SHARES
AT HK$0.85 PER SUBSCRIPTION SHARE
Source text for Eikon: ID:
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital